![Michael Nohaile](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Nohaile
Directeur/Bestuurslid bij
FULGENT GENETICS, INC.
Vermogen: 445 845 $ op 31-05-2026
Profiel
Michael Nohaile is currently Chief Executive Officer at Prellis Biologics, Inc. since 2022 and Independent Director at Fulgent Genetics, Inc. since 2022.
Former roles include Director at Genoptix, Inc., Chief Scientific Officer at Generate Biomedicines, Inc. from 2021 to 2022, Senior VP-Strategy, Commercialization & Innovation at Amgen, Inc. from 2012 to 2021, Global Head-Molecular Diagnostics at Novartis AG from 2008 to 2012, General Manager-Molecular Diagnostics Business at Novartis Corp.
from 2007 to 2012, and Partner at McKinsey & Co., Inc. from 2000 to 2007.
Education includes undergraduate studies at Massachusetts Institute of Technology and a doctorate from the University of California, Berkeley.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-05-2026 | 24.578 ( 0,08% ) | 445 845 $ | 31-05-2026 |
Actieve functies van Michael Nohaile
| Bedrijven | Functie | Begin |
|---|---|---|
| FULGENT GENETICS, INC. | Directeur/Bestuurslid | 01-08-2022 |
Prellis Biologics, Inc.
 Prellis Biologics, Inc. BiotechnologyHealth Technology Develops novel technology to bio print vascularized human tissues | Algemeen Directeur | 11-08-2022 |
Eerdere bekende functies van Michael Nohaile
| Bedrijven | Functie | Einde |
|---|---|---|
| GENERATE BIOMEDICINES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2022 |
| AMGEN INC. | Corporate Officer/Principal | 01-02-2021 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Corporate Officer/Principal | 01-11-2012 |
| NOVARTIS AG | Corporate Officer/Principal | 01-11-2012 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | 01-01-2007 |
Opleiding van Michael Nohaile
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
97
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genoptix, Inc.
 Genoptix, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine services | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fulgent Genetics, Inc.
 Fulgent Genetics, Inc. Medical/Nursing ServicesHealth Services Provides genetic diagnostics services | Health Services |
Prellis Biologics, Inc.
Prellis Biologics, Inc. BiotechnologyHealth Technology Develops novel technology to bio print vascularized human tissues | Health Technology |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Operates as a clinical-stage generative biology company that provides biotechnology and drug design & development services | Health Technology |
